Assenagon Asset Management S.A. Coherus Bio Sciences, Inc. Transaction History

Assenagon Asset Management S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 19, 2021	SELL	$12.68 - $17.79 $1.17 Million - $1.63 Million	-91,886 Closed	0 $0
Q2 2021 Jul 15, 2021	BUY	$12.95 - $15.41 $211,991 - $252,261	16,370 Added 21.68%	91,886 $1.27 Million
Q1 2021 Apr 26, 2021	BUY	$14.42 - $21.39 $181,360 - $269,022	12,577 Added 19.98%	75,516 $1.1 Million
Q4 2020 Feb 01, 2021	BUY	$16.56 - $18.94 $255,023 - $291,676	15,400 Added 32.39%	62,939 $1.09 Million
Q3 2020 Oct 07, 2020	SELL	$17.41 - $19.89 $43,995 - $50,262	-2,527 Reduced 5.05%	47,539 $872,000
Q2 2020 Jul 21, 2020	BUY	$14.43 - $19.16 $722,452 - $959,264	50,066 New	50,066 $894,000

132

77.3M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $87.1M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.